K211858 is an FDA 510(k) clearance for the TULSA-PRO System. This device is classified as a High Intensity Ultrasound System For Prostate Tissue Ablation (Class II - Special Controls, product code PLP).
Submitted by Profound Medical, Inc. (Mississauga, CA). The FDA issued a Cleared decision on September 6, 2022, 447 days after receiving the submission on June 16, 2021.
This device falls under the Gastroenterology & Urology FDA review panel. Regulated under 21 CFR 876.4340. Prostate Tissue Ablation.
| 510(k) Number | K211858 FDA.gov |
| FDA Decision | Cleared Substantially Equivalent - Traditional 510(k) (SESE) |
| Date Received | June 16, 2021 |
| Decision Date | September 06, 2022 |
| Days to Decision | 447 days |
| Submission Type | Traditional |
| Review Panel | Gastroenterology & Urology (GU) |
| Summary | Summary PDF |
| Product Code | PLP - High Intensity Ultrasound System For Prostate Tissue Ablation |
| Device Class | Class II - Special Controls |
| CFR Regulation | 21 CFR 876.4340 |
| Definition | Prostate Tissue Ablation |